|
2023-08-22 |
2023-08-21 |
A
Achat
|
Kandera Reinhard
Chief Financial Officer
Administrateur exécutif
|
7 000
+19.4%
0,73
5 075 USD
|
7 000
+19.4%
|
0,73
|
5 075 USD
|
|
|
2023-08-17 |
2023-08-16 |
A
Achat
|
Kandera Reinhard
Chief Financial Officer
Administrateur exécutif
|
8 000
+28.5%
0,71
5 712 USD
|
8 000
+28.5%
|
0,71
|
5 712 USD
|
|
|
2023-07-11 |
2023-07-11 |
A
Achat
|
Aldag Jorn
Chief Executive Officer
Administrateur exécutif
|
5 000
+7.5%
0,83
4 142 USD
|
5 000
+7.5%
|
0,83
|
4 142 USD
|
|
|
2023-07-11 |
2023-07-07 |
A
Achat
|
Aldag Jorn
Chief Executive Officer
Administrateur exécutif
|
5 000
+8.1%
0,81
4 050 USD
|
5 000
+8.1%
|
0,81
|
4 050 USD
|
|
|
2023-07-07 |
2023-07-05 |
A
Achat
|
Aldag Jorn
Chief Executive Officer
Administrateur exécutif
|
5 000
+8.8%
0,89
4 450 USD
|
5 000
+8.8%
|
0,89
|
4 450 USD
|
|
|
2023-07-05 |
2023-07-03 |
A
Achat
|
Aldag Jorn
Chief Executive Officer
Administrateur exécutif
|
5 000
+9.6%
0,89
4 456 USD
|
5 000
+9.6%
|
0,89
|
4 456 USD
|
|
|
2023-07-03 |
2023-06-30 |
A
Achat
|
Kandera Reinhard
Chief Financial Officer
Administrateur exécutif
|
12 000
+74.6%
0,88
10 560 USD
|
12 000
+74.6%
|
0,88
|
10 560 USD
|
|
|
2022-01-12 |
2021-12-21 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
2 205
-2.5%
2,49
5 490 USD
|
2 205
-2.5%
|
2,49
|
5 490 USD
|
|
|
2022-01-12 |
2021-12-21 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
7 440
-8.1%
2,49
18 526 USD
|
7 440
-8.1%
|
2,49
|
18 526 USD
|
|
|
2022-01-12 |
2021-12-21 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
5 304
-6.2%
2,49
13 207 USD
|
5 304
-6.2%
|
2,49
|
13 207 USD
|
|
|
2021-04-23 |
2021-04-21 |
V
Vente
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
328 620
-9.4%
11,60
3 812 386 USD
|
328 620
-9.4%
|
11,60
|
3 812 386 USD
|
|
|
2021-03-29 |
2021-03-25 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
28 546
-0.8%
13,12
374 569 USD
|
28 546
-0.8%
|
13,12
|
374 569 USD
|
|
|
2021-03-26 |
2021-03-24 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
52 690
-1.4%
13,70
721 616 USD
|
52 690
-1.4%
|
13,70
|
721 616 USD
|
|
|
2021-03-25 |
2021-03-23 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
40 000
-1.1%
13,91
556 476 USD
|
40 000
-1.1%
|
13,91
|
556 476 USD
|
|
|
2021-03-24 |
2021-03-22 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
40 534
-1.1%
14,54
589 263 USD
|
40 534
-1.1%
|
14,54
|
589 263 USD
|
|
|
2021-03-23 |
2021-03-19 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
166 230
-4.3%
14,60
2 427 739 USD
|
166 230
-4.3%
|
14,60
|
2 427 739 USD
|
|
|
2020-12-18 |
2020-12-17 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
16 478
-17.6%
11,76
193 781 USD
|
16 478
-17.6%
|
11,76
|
193 781 USD
|
|
|
2020-12-18 |
2020-12-17 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
11 501
-15.2%
11,70
134 562 USD
|
11 501
-15.2%
|
11,70
|
134 562 USD
|
|
|
2020-12-18 |
2020-12-16 |
V
Vente
|
Matushansky Igor
Chief Medical Officer
Dirigeant
|
380
-0.7%
11,70
4 446 USD
|
380
-0.7%
|
11,70
|
4 446 USD
|
|
|
2020-10-06 |
2020-10-02 |
VP
Vente planifiée
|
SOFINNOVA CAPITAL VI FCPR
Actionnaire important
|
300
-0.0%
10,00
3 000 USD
|
300
-0.0%
|
10,00
|
3 000 USD
|
|
